Back to search

Article

A multigene circulating biomarker to predict the lack of FOLFIRINOX response after a single cycle in patients with pancreatic ductal adenocarcinoma (PDAC)

2022-09-02

Abstract excerpt

<h4>Introduction: </h4> FOLFIRINOX chemotherapy showed promising results in treating patients with pancreatic ductal adenocarcinoma (PDAC). However, many patients and physicians are reluctant to start FOLFIRINOX due to its high toxicity and limited clinical response rates. In this study, we investigated the effect of a single cycle of FOLFIRINOX, in combination with a granulocyte colony-stimulating factor (G-CSF),...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
187ea473-8446-5478-a5cf-12f96d540be0
DOI
10.21203/rs.3.rs-2008977/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A multigene circulating biomarker to predict the lack of FOLFIRINOX response after a single cycle in patients with pancreatic ductal adenocarcinoma (PDAC)DOI 10.21203/rs.3.rs-2008977/v1
Single-cell transcriptomics analysis reveals dynamic changes and prognostic signature in tumor microenvironment of PDACSemantic proximity
Tumor immune-gene expression profiles and peripheral immune phenotypes associated with clinical outcomes of locally advanced pancreatic cancer following FOLFIRINOX.Semantic proximity
Identification and Validation of T Cell Exhaustion Signature for Predicting Prognosis and Immune Response in Pancreatic Cancer by Integrated Analysis of Single-Cell and Bulk RNA Sequencing DataSemantic proximity
Novel Insights into T-Cell Exhaustion and Cancer Biomarkers in PDAC Using ScRNA-SeqSemantic proximity
A 15-Gene Immune, Stromal, and Proliferation Gene Signature that Significantly Associates with Poor Survival in Patients with Pancreatic Ductal AdenocarcinomaSemantic proximity
Prognostic value of eight immune gene signatures in pancreatic cancer patientsSemantic proximity
A transcriptomics-based meta-analysis combined with machine learning approach identifies a secretory biomarker panel for diagnosis of pancreatic adenocarcinomaSemantic proximity
A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinomaSemantic proximity
Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal AdenocarcinomaSemantic proximity
A comprehensive transcriptional signature in pancreatic ductal adenocarcinoma reveals new insights into the immune and desmoplastic microenvironmentSemantic proximity
Identification of Blood-based Non-invasive Biomarkers and Therapeutic Agents against Pancreatic Ductal Adenocarcinoma (PDAC): A Network-based StudySemantic proximity
Novel drug resistance- and macrophage polarization-related molecular subtyping and prognostic signature for pancreatic adenocarcinomaSemantic proximity
Select a neighboring publication to make it the new centre.